Company Filing History:
Years Active: 2003
Title: Muthiah Monoharan: Innovator in Oligonucleotide Therapies
Introduction
Muthiah Monoharan is a notable inventor based in Carlsbad, California. He has made significant contributions to the field of biotechnology, particularly in the development of oligonucleotide therapies. His work focuses on enhancing the efficacy of antisense oligonucleotide therapies, which are crucial in treating various genetic disorders.
Latest Patents
Muthiah Monoharan holds a patent titled "Human RNase H1 and oligonucleotide compositions thereof." This invention provides oligonucleotides that serve as substrates for human Type 2 RNase H. The patent also outlines methods for using these oligonucleotides to enhance antisense oligonucleotide therapies. He has 1 patent to his name, showcasing his innovative approach in this specialized area.
Career Highlights
Monoharan is associated with Isis Pharmaceuticals, Inc., a company known for its pioneering work in RNA-targeted therapies. His role at the company has allowed him to contribute to groundbreaking research and development in the field of oligonucleotides.
Collaborations
Throughout his career, Muthiah Monoharan has collaborated with esteemed colleagues, including Stanley T. Crooke and Walter F. Lima. These collaborations have further enriched his research and have played a vital role in advancing the field of biotechnology.
Conclusion
Muthiah Monoharan's contributions to oligonucleotide therapies highlight his innovative spirit and dedication to improving medical treatments. His work continues to influence the biotechnology landscape, paving the way for future advancements in the field.